UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000030223 |
|---|---|
| Receipt number | R000034524 |
| Scientific Title | The assessment of associaed factor for metabolic disease in a community-based Study |
| Date of disclosure of the study information | 2017/12/02 |
| Last modified on | 2021/12/19 11:39:40 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The assessment of associaed factor for metabolic disease in a community-based Study
Acronym
Associated factor for metabolic disease
Scientific Title
The assessment of associaed factor for metabolic disease in a community-based Study
Scientific Title:Acronym
Associated factor for metabolic disease
Region
| Japan |
Condition
Condition
metabolic disease
Classification by specialty
| Medicine in general | Gastroenterology | Hepato-biliary-pancreatic medicine |
| Endocrinology and Metabolism |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To identify undiagnosed cases of metabolic disease and atherosclerotic disease, this study examine the associated factor for diagnosing metabolic disease and atherosclerotic disease, and explore the predictive factors for onset of metabolic disease, atherosclerotic disease, and cancer.
Basic objectives2
Others
Basic objectives -Others
Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
1. Identify the associated factor for metabolic disease
Key secondary outcomes
1. Identify the associated factor for nonalcoholic fatty liver disease
2. Identify the associated factor for abnormal glucose tolerance
3. Identify the associated factor for dyslipidemia
4. Identify the associated factor for hypertension
5. Identify the associated factor for hyperuricemia
6. Identify the associated factor for metabolic syndrome
7. Identify the associated factor for atherosclerotic disease
8. Explore the predictive factor for onset of nonalcoholic fatty liver disease
9. Explore the predictive factor for onset of abnormal glucose tolerance
10. Explore the predictive factor for onset of dyslipidemia
11. Explore the predictive factor for onset of hypertension
12. Explore the predictive factor for onset of hyperuricemia
13. Explore the predictive factor for onset of metabolic syndrome
14. Explore the predictive factor for onset of atherosclerotic disease
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 90 | years-old | > |
Gender
Male and Female
Key inclusion criteria
The subjects undergo annual health check-up.
Key exclusion criteria
The subjects with data points missing.
Target sample size
30000
Research contact person
Name of lead principal investigator
| 1st name | Teruki |
| Middle name | |
| Last name | Miyake |
Organization
Ehime University Graduate School of Medicine
Division name
Department of Gastroenterology and Metabology
Zip code
7910295
Address
Toon City, Ehime, Japan
TEL
+81899605308
teruki-ygc@umin.ac.jp
Public contact
Name of contact person
| 1st name | Teruki |
| Middle name | |
| Last name | Miyake |
Organization
Ehime University Graduate School of Medicine
Division name
Department of Gastroenterology and Metabology
Zip code
7910295
Address
Toon city, Ehime
TEL
+81899605308
Homepage URL
teruki-ygc@umin.ac.jp
Sponsor or person
Institute
Ehime University
Institute
Department
Personal name
Funding Source
Organization
Self funding
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethics Committee of Ehime University Hospital
Address
454 Shitsukawa Toon Ehime japan
Tel
+81899605914
cttc@m.ehime-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 12 | Month | 02 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2017 | Year | 07 | Month | 27 | Day |
Date of IRB
Anticipated trial start date
| 2017 | Year | 12 | Month | 02 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
To identify undiagnosed cases of metabolic disease and atherosclerotic disease, this study examine the associated factor for diagnosing metabolic disease and atherosclerotic disease, and explore the predictive factors for onset of metabolic disease, atherosclerotic disease, and cancer.
Management information
Registered date
| 2017 | Year | 12 | Month | 02 | Day |
Last modified on
| 2021 | Year | 12 | Month | 19 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034524
